A yellow light for nitric oxide synthase inhibitors in sepsis
- 1 May 1998
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 26 (5), 815-816
- https://doi.org/10.1097/00003246-199805000-00005
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Response of the septic vasculature to prolonged vasopressor therapy with N (omega-monomethyl-L-arginine) and epinephrine in caninesCritical Care Medicine, 1998
- L-arginineCritical Care Medicine, 1995
- Endothelial and vascular smooth muscle function in sepsisJournal of Critical Care, 1994
- Nitric oxide decreases [Ca2+]i in vascular smooth muscle by inhibition of the calcium currentCell Calcium, 1994
- L-arginine pathway in the sepsis syndromeCritical Care Medicine, 1993
- Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?The Lancet, 1991
- Nitrogen Oxide Levels in Patients After Trauma and During SepsisAnnals of Surgery, 1991
- The effect of inhibitors of the l‐arginine/nitric oxide pathway on endotoxin‐induced loss of vascular responsiveness in anaesthetized ratsBritish Journal of Pharmacology, 1991
- Myocardial Dysfunction in Sepsis Recent InsightsChest, 1989
- Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.JCI Insight, 1986